NGL Fine Chem - NGL Fine - Chem Share Price

2,989.90-83.70 (-2.73%)

Closed
As On: 25 Jun, 2026, 04:03 PM IST
As On: 25 Jun, 2026, 03:49 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	3,073.00
High	3,131.90
Low	2,925.20
Prev Close	3,073.60
Volume	15,468
VWAP(₹)	3,014.74

Share Price	Value
Today/Current/Last	2,989.902,932.40
Previous Day	3,073.603,081.60

NGL Fine Chem Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

News & Analysis

View all NGL Fine Chem Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

Income (P&L)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	151.69	132.12	122.31	110.54	94.01
Total Income Growth (%)	14.81	8.02	10.65	17.59	5.66
Total Expenses	132.87	110.38	108.19	97.48	91.97
Total Expenses Growth (%)	20.38	2.02	10.99	5.99	5.59
EBIT	18.82	21.74	14.12	13.06	2.03
EBIT Growth (%)	-13.45	53.96	8.13	542.22	9.00
Profit after Tax (PAT)	13.49	15.69	9.63	9.24	0.54
PAT Growth (%)	-14.05	63.01	4.17	1,599.89	-57.42
EBIT Margin (%)	12.41	16.46	11.55	11.82	2.16
Net Profit Margin (%)	8.89	11.88	7.87	8.36	0.58
Basic EPS (₹)	21.83	25.40	15.58	14.96	0.88

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	147.26	131.02	119.25	107.41	92.23
Total Income Growth (%)	12.39	9.87	11.02	16.46	6.03
Total Expenses	131.39	110.59	107.44	96.49	91.64
Total Expenses Growth (%)	18.81	2.93	11.35	5.29	7.09
EBIT	15.87	20.43	11.81	10.92	0.59
EBIT Growth (%)	-22.32	72.98	8.13	1,762.09	-58.44
Profit after Tax (PAT)	11.35	14.74	7.90	7.64	-0.52
PAT Growth (%)	-22.95	86.59	3.32	-	-166.50
EBIT Margin (%)	10.78	15.59	9.90	10.17	0.64
Net Profit Margin (%)	7.71	11.25	6.62	7.12	-0.56
Basic EPS (₹)	18.38	23.85	12.78	12.37	-0.84

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	515.68	376.89	352.82	283.61	328.19
Total Revenue Growth (%)	36.83	6.82	24.40	-13.58	23.38
Total Expenses	452.32	349.17	298.40	256.25	261.59
Total Expenses Growth (%)	29.54	17.02	16.45	-2.04	38.85
Profit after Tax (PAT)	48.13	21.12	41.32	20.50	49.90
PAT Growth (%)	127.83	-48.87	101.58	-58.92	-12.03
Operating Profit Margin (%)	13.54	8.15	16.46	10.27	21.46
Net Profit Margin (%)	9.60	5.73	12.19	7.37	15.71
Basic EPS (₹)	77.90	34.19	66.88	33.18	80.77

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	503.63	369.05	344.87	282.66	331.31
Total Revenue Growth (%)	36.46	7.01	22.01	-14.68	24.21
Total Expenses	449.01	345.17	294.17	256.07	262.33
Total Expenses Growth (%)	30.08	17.34	14.88	-2.39	37.54
Profit after Tax (PAT)	41.63	18.13	38.52	20.12	52.25
PAT Growth (%)	129.61	-52.93	91.46	-61.49	-5.81
Operating Profit Margin (%)	12.07	7.28	15.82	10.10	22.13
Net Profit Margin (%)	8.51	5.04	11.70	7.31	16.39
Basic EPS (₹)	67.39	29.35	62.35	32.56	84.57

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 36.83% outperformed its 3 year CAGR of 21.81%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 13.08% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

View Details

Balance Sheet

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	545.50	433.39	355.54	287.08	276.93
Total Assets Growth (%)	25.87	21.90	23.85	3.67	33.29
Total Liabilities	216.27	150.96	92.90	64.53	73.71
Total Liabilities Growth (%)	43.26	62.49	43.97	-12.45	38.27
Total Equity	329.23	282.43	262.63	222.55	203.22
Total Equity Growth (%)	16.57	7.54	18.01	9.51	31.57
Current Ratio (x)	1.84	1.98	2.46	2.79	2.64
Total Debt to Equity (x)	0.33	0.26	0.12	0.14	0.13
Contingent Liabilities	0.00	13.47	19.86	14.11	14.83

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	529.63	425.76	353.05	288.11	277.72
Total Assets Growth (%)	24.40	20.59	22.54	3.74	34.70
Total Liabilities	209.69	146.15	90.24	62.59	71.16
Total Liabilities Growth (%)	43.48	61.96	44.18	-12.04	40.30
Total Equity	319.94	279.61	262.81	225.52	206.56
Total Equity Growth (%)	14.42	6.39	16.54	9.18	32.88
Current Ratio (x)	1.84	2.01	2.41	2.81	2.69
Total Debt to Equity (x)	0.34	0.26	0.12	0.14	0.13
Contingent Liabilities	0.00	12.83	19.40	13.90	14.42

All figures in Rs Cr, unless mentioned otherwise

View Details

Cash Flows

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	43.32	35.82	20.47	35.29	13.82
Net Cash used in Investing Activities	-70.59	-34.55	-26.82	-27.02	-14.20
Net Cash flow from Financing Activities	29.55	-1.08	-1.08	-1.08	-1.08
Net Cash Flow	2.81	0.19	-7.43	7.18	-1.46
Closing Cash & Cash Equivalent	2.81	0.58	0.40	7.83	0.64
Closing Cash & Cash Equivalent Growth (%)	381.40	47.60	-94.95	1,115.97	-69.39
Total Debt/ CFO (x)	2.50	2.04	1.59	0.86	1.94

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	34.73	17.02	11.14	31.89	12.69
Net Cash used in Investing Activities	-64.57	-15.75	-17.49	-23.62	-13.00
Net Cash flow from Financing Activities	29.87	-1.08	-1.08	-1.08	-1.08
Net Cash Flow	0.03	0.19	-7.44	7.19	-1.40
Closing Cash & Cash Equivalent	0.55	0.57	0.39	7.82	0.64
Closing Cash & Cash Equivalent Growth (%)	-4.22	48.29	-95.06	1,128.25	-68.66
Total Debt/ CFO (x)	3.10	4.24	2.91	0.96	2.12

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 70.59 cr for investing activities which is an YoY increase of 104.3%. (Source: Consolidated Financials)

View Details

Ratios

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	14.61	7.47	15.73	9.20	24.55
Return on Capital Employed (%)	17.15	9.55	20.73	12.48	32.26
Return on Assets (%)	8.82	4.87	11.62	7.13	18.01
Interest Coverage Ratio (x)	19.57	18.21	50.37	33.29	50.29
Asset Turnover Ratio (x)	1.02	0.93	1.05	0.97	1.31
Price to Earnings (x)	26.60	32.68	31.35	36.10	24.27
Price to Book (x)	3.89	2.44	4.92	3.32	5.95
EV/EBITDA (x)	15.82	17.78	19.61	18.99	15.73
EBITDA Margin (%)	17.45	11.54	19.89	14.33	24.73

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	13.01	6.48	14.65	8.92	25.29
Return on Capital Employed (%)	15.30	8.41	19.37	12.00	32.86
Return on Assets (%)	7.86	4.25	10.91	6.98	18.81
Interest Coverage Ratio (x)	17.11	15.37	44.98	29.82	50.08
Asset Turnover Ratio (x)	1.02	0.92	1.03	0.97	1.32
Price to Earnings (x)	30.77	38.02	33.56	36.76	23.20
Price to Book (x)	4.00	2.46	4.91	3.28	5.86
EV/EBITDA (x)	18.38	21.29	21.96	21.21	15.80
EBITDA Margin (%)	15.40	9.86	18.29	12.97	24.54

Found Financials useful?

5 Days	14 Days	28 Days
-	-	-

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
NGL Fine Chem	38.45	5.61	14.61	17.15	8.82	21.81	13.54	9.60	77.90	1.84	0.33	2.50
Venus Remedies	25.32	3.92	15.48	19.39	12.03	11.28	17.43	13.35	76.89	2.44	0.00	0.00
Kwality Pharmaceutic	37.58	7.67	20.31	27.62	11.37	25.54	20.13	13.38	64.90	1.80	0.39	7.87
Beta Drugs	56.03	9.50	16.94	17.98	8.36	20.01	18.11	10.77	40.92	3.10	0.60	3.96
Indoco Remedies	-22.47	2.29	-10.13	1.21	-3.66	3.39	1.01	-5.34	-10.70	1.13	1.10	5.39
Add More

Annual Ratios (%)

Choose from Peers

Ind-Swift Labs
Amrutanjan Health Care
Jagsonpal Pharm
Syncom Form
Lincoln Pharma

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
NGL Fine Chem Stock Performance	-2.73	31.62	32.41	27.42	132.57	96.68	0.00
Venus Remedies Stock Performance	5.00	107.64	90.14	156.40	456.44	872.04	506.92
Kwality Pharmaceutic Stock Performance	-0.66	45.08	53.75	0.00	0.00	0.00	0.00
Beta Drugs Stock Performance	-3.14	49.37	59.26	97.46	17.13	200.76	663.84
Indoco Remedies Stock Performance	-2.37	2.69	8.63	16.82	-11.46	-34.04	-33.59
Add More

Category	No. of Shares	Percentage	% Change QoQ
Promoters	44,93,646	72.74 %	0.00
Pledge	0	0.00 %	0.00
FII	1,684	0.03 %	0.03
DII	62	0.00 %	0.00
MF	62	0.00 %	0.00
Others	16,82,632	27.23 %	-0.03

Category	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Promoters	72.74	72.74	72.74	72.74
Pledge	0.00	0.00	0.00	0.00
FII	0.03	0.00	0.00	0.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	27.23	27.26	27.26	27.26

Mutual Funds Ownership

No Data Available

Corporate Actions

Recent
General Meeting
-
May 21, 2026
Final
35%
May 21, 2026
Board Meeting
Audited Results
May 18, 2026

Board Meetings

Announced on	Meeting on
May 18, 2026	May 21, 2026
Audited Results
Jan 12, 2026	Feb 03, 2026
Quarterly Results
Nov 03, 2025	Nov 12, 2025
Quarterly Results
Jul 22, 2025	Aug 01, 2025
Quarterly Results
May 05, 2025	May 22, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 22, 2025 Aug 12, 2025 35%
May 21, 2024 Aug 16, 2024 35%
May 15, 2023 Aug 18, 2023 35%
May 02, 2022 Jun 22, 2022 35%
May 21, 2026 - 35%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
May 21, 2026 Aug 25, 2026
-
May 22, 2025 Aug 19, 2025
-
May 21, 2024 Aug 23, 2024
Book closure from Aug 17, 2024 to Aug 23, 2024
May 15, 2023 Aug 25, 2023
-
May 02, 2022 Jun 30, 2022
-

Announced on	Ex-Date	Dividend%
May 22, 2025	Aug 12, 2025	35%
May 21, 2024	Aug 16, 2024	35%
May 15, 2023	Aug 18, 2023	35%
May 02, 2022	Jun 22, 2022	35%
May 21, 2026	-	35%

Announced on	Meeting on
May 21, 2026	Aug 25, 2026
-
May 22, 2025	Aug 19, 2025
-
May 21, 2024	Aug 23, 2024
Book closure from Aug 17, 2024 to Aug 23, 2024
May 15, 2023	Aug 25, 2023
-
May 02, 2022	Jun 30, 2022
-

About NGL Fine Chem

NGL Fine - Chem Ltd., incorporated in the year 1981, is a Small Cap company (having a market cap of Rs 1,847.17 Crore) operating in Pharmaceuticals sector.

NGL Fine - Chem Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 151.69 Crore, up 14.81 % from last quarter Total Income of Rs 132.12 Crore and up 61.36 % from last year same quarter Total Income of Rs 94.01 Crore. Company has reported net profit after tax of Rs 13.49 Crore in latest quarter.

The company’s top management includes Mr.Dhananjay Mungale, Mr.Rahul Nachane, Mr.Rajesh Narayan Lawande, Mrs.Ajita R Nachane, Mrs.Jayaram Sitaram, Ms.Sarala Menon, Mrs.Pallavi Pednekar. Company has Manek & Associates as its auditors. As on 31-03-2026, the company has a total of .62 Crore shares outstanding.

NGL Fine Chem Share Price Today is Rs. 2989.90. On previous day, the NGL Fine Chem Share Price (NSE) closed at Rs. 3073.6, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 72.74% of the stake in NGL Fine Chem shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of NGL Fine Chem stocks was 0.03% as compared to 0.0% in Dec 2025 with decrease of 0.0%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.0% as compared to 0.0% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in NGL Fine Chem shares 0.0% was held by mutual funds. The rest including public held is 27.23%. NGL Fine Chem stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
NGL Fine Chem Dividend: Ever since 1981, NGL Fine Chem dividends has been paid out around 11 times. As on 25 Jun, 2026, 04:03 PM IST, The overall dividend yield for NGL Fine Chem stands at 0.06%. The last dividend paid was on null (Rs. 1.75). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 77.76.

NGL Fine Chem Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 151.69 Cr. of sales and 14.81% of quarterly net profit, there have been multiple ups and downs in the NGL Fine Chem stock prices in the past few weeks. For example, NGL Fine Chem stock price on 19th of June 2026 was around Rs. 3045.4. NGL Fine Chem share price now stands at an average of Rs. 2989.90. Judging by last week's performance, stock is in up trend.

NGL Fine Chem has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for NGL Fine Chem share.

Historical Prices and Performance:
NGL Fine Chem, incorporated in 1981 is a Small Cap company (with a market cap of Rs. 1847.17) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by NGL Fine Chem stock was 14.61%, 7.47%, 15.73%, 9.2% and 24.55% respectively.
The NGL Fine Chem share gave a 3 year return of 78.35% as compared to Nifty 50 which gave a return of 28.88%.
NGL Fine Chem announced 35.0% final dividend on null.

Key Metrics:
PE Ratio of NGL Fine Chem is 38.45
Prices/Sales Ratio of NGL Fine Chem is 2.55
Price/Book Ratio of NGL Fine Chem is 5.61

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For NGL Fine Chem, major competitors and peers include Venus Remedies, Kwality Pharmaceutic, Beta Drugs and Indoco Remedies. As of Dec 2025, the dividend yield of NGL Fine Chem stands at 0.06% while Venus Remedies, Kwality Pharmaceutic, Beta Drugs and Indoco Remedies stand at 0.51%, 0.01%, 0.0% and 0.09% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 38.45 and 5.61 respectively.

Leadership of NGL Fine Chem :
Pallavi Pednekar is Co. Secretary & Compl. Officer
Dhananjay Mungale is Chairman & Ind.Director
Rahul Nachane is Managing Director
Rajesh Narayan Lawande is WholeTime Director & CFO
Sarala Menon is Ind. Non-Executive Woman Director
Ajita R Nachane is Non Executive Woman Director
Jayaram Sitaram is Independent Director

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE MidSmallCap

Address

301, E Square,Subhash Road,New Mumbai, Maharashtra - 400057

Contact

cs@nglfinechem.com

http://www.nglfinechem.com

PE Ratio(x)	38.45
EPS - TTM(₹)	77.76
MCap(₹ Cr.)	1,847.17
MCap Rank	82
PB Ratio(x)	5.77
Div Yield(%)	0.06
Face Value(₹)	5.00
52W High(₹)	3,232.00
52W Low(₹)	1,000.00
MCap/Sales	2.55
Beta(1 Month)	-
BV/Share(₹)	532.90

PE Ratio(x)	37.71
EPS - TTM(₹)	77.76
MCap(₹ Cr.)	1,811.64
MCap Rank	80
PB Ratio(x)	5.78
Div Yield(%)	0.06
Face Value(₹)	5.00
52W High(₹)	3,227.90
52W Low(₹)	1,000.00
MCap/Sales	2.55
Beta(1 Month)	0.70
BV/Share(₹)	532.90

1 Day	-2.73%
1 Month	6.03%
3 Months	33.42%
1 Year	189.16%
3 Years	80.63%
5 Years	N.A.

1 Day	-4.84%
1 Month	3.72%
3 Months	30.69%
1 Year	184.63%
3 Years	77.19%
5 Years	43.21%

R1	-	Pivot -	S1	-
R2	-		S2	-
R3	-		S3	-

NGL Fine Chem - NGL Fine - Chem Share Price

Key Metrics

NGL Fine Chem share price insights

NGL Fine Chem Share Price Returns

NGL Fine Chem Share Recommendations

News & Analysis

Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

Financials

Technicals

Peer Comparison

Shareholding Pattern

Mutual Funds Ownership

NGL Fine Chem Top Searches

Corporate Actions

About NGL Fine Chem

Executive Leadership

Auditors

FAQs about NGL Fine Chem share

Top Gainers

Top Losers

Equity Quick Links

More from Markets

Trending in Markets

Browse Companies

Popular Categories

Hot on Web

In Case you missed it

Top Searched Companies

Latest News